- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02569060
Feeding America Intervention Trial for Health--Diabetes Mellitus (FAITH-DM)
May 14, 2020 updated by: University of California, San Francisco
The Feeding America Intervention Trial for Health-Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings.
Study Overview
Status
Completed
Conditions
Detailed Description
For adults with diabetes mellitus, diabetes self-management education (DSME) is critical to achieving long-term control of blood sugar levels (glycemic control) and preventing diabetes-associated complications.
This education is often difficult to access for highly vulnerable and marginalized adults in the United States.
Furthermore, foods for a diabetic diet are often out of reach for food insecure households.
The purpose of this study is to determine the extent to which food banks and food pantries can help reach this population with effective DSME, food, and access to primary health care.
The investigators' primary outcome of interest is HbA1c improvement in the intervention group compared to a wait-listed control group of food pantry clients living with uncontrolled type 2 diabetes.
Study Type
Interventional
Enrollment (Actual)
568
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Oakland, California, United States, 94614
- Alameda County Community Food Bank
-
San Francisco, California, United States, 94143
- University of California San Francisco
-
-
Michigan
-
Detroit, Michigan, United States, 48207
- Gleaners Community Food Bank of Southeastern Michigan
-
-
Texas
-
Houston, Texas, United States, 77029
- Houston Food Bank
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX)
- Type II diabetes mellitus with HbA1c ≥ 7.5% using food bank point-of-care testing
- Reliable mode of contact (either phone or address)
- English or Spanish verbal fluency
- 18 years of age or older
- Intent to remain in the study area for at least the next 12 months
- Willingness to participate in intervention
Exclusion Criteria:
- Type 1 diabetes
- Pregnant or less than 6 weeks post-partum
- Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention
- Household member already enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate Intervention
Participants randomized to the Intervention Arm will immediately begin a four-component intervention.
|
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Referral to a local primary care provider, if none currently exists.
Coordination of care with primary care provider.
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations.
The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.
|
Active Comparator: Waitlist Control
Participants randomized to the Waitlist Control arm will receive no intervention for six months, after which time they will begin a modified, four-component intervention.
|
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Referral to a local primary care provider, if none currently exists.
Coordination of care with primary care provider.
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations.
The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline HbA1c at 6 Months
Time Frame: 6 months
|
Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Dietary Intake
Time Frame: 6 months and 12 months
|
Brief fruit & vegetable dietary screener
|
6 months and 12 months
|
Change from Baseline Health Care Utilization
Time Frame: 6 months and 12 months
|
Communication with primary care provider requesting dates of service, service levels, and diagnosis codes
|
6 months and 12 months
|
Change from Baseline Diabetes Distress
Time Frame: 6 months and 12 months
|
Self-reported distress as assessed by the 2-item emotional burden sub-score of the Diabetes Distress Scale
|
6 months and 12 months
|
Change from Baseline Hypoglycemic events
Time Frame: 6 months and 12 months
|
Self-reported hypoglycemic events over the previous 4 weeks, both any events and number of events, and self-reported severe hypoglycemic episodes, both any events and number of events
|
6 months and 12 months
|
Change from Baseline Depressive symptoms
Time Frame: 6 months and 12 months
|
PHQ-8 (a subset of PHQ-9 scores without assessment of suicidality)
|
6 months and 12 months
|
Change from Baseline Medication Adherence
Time Frame: 6 months and 12 months
|
Morisky Medication Adherence Scale (4 items)
|
6 months and 12 months
|
Food vs medicine trade-offs
Time Frame: 6 months and 12 months
|
Three self-reported questions
|
6 months and 12 months
|
Change from Baseline Food security status
Time Frame: 6 months and 12 months
|
6-item version of the USDA's Core Food Security Survey Module
|
6 months and 12 months
|
Change from Baseline Food stability
Time Frame: 6 months and 12 months
|
Two items assessing adequacy of food resources to last the entire month
|
6 months and 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Diabetes Self-Efficacy
Time Frame: 6 months and 12 months
|
8-item scale of diabetes-specific self-efficacy
|
6 months and 12 months
|
Change from Baseline Diabetes Self-Care
Time Frame: 6 months and 12 months
|
Self-reported assessment of 5 self-care behaviors: medications, exercise, diet, blood sugar monitoring, and foot care
|
6 months and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hilary K Seligman, MD MAS, University of California, San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Seligman HK, Levi R, Ridberg R, Smith M, Hills N, Waxman E. Impact of Enhanced Food Pantry Services on Food Security among Adults with Diabetes Using a Crossover Study Design. Curr Dev Nutr. 2022 Feb 10;6(4):nzac021. doi: 10.1093/cdn/nzac021. eCollection 2022 Apr.
- Smith M, Rosenmoss S, Seligman HK. Point-of-Care Hemoglobin A1C Testing System in Community Settings: Challenges, Opportunities, and Measurement Characteristics. Prog Community Health Partnersh. 2020;14(3):327-335. doi: 10.1353/cpr.2020.0038.
- Seligman HK, Smith M, Rosenmoss S, Marshall MB, Waxman E. Comprehensive Diabetes Self-Management Support From Food Banks: A Randomized Controlled Trial. Am J Public Health. 2018 Sep;108(9):1227-1234. doi: 10.2105/AJPH.2018.304528. Epub 2018 Jul 19.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
October 31, 2017
Study Completion (Actual)
October 31, 2017
Study Registration Dates
First Submitted
October 2, 2015
First Submitted That Met QC Criteria
October 5, 2015
First Posted (Estimate)
October 6, 2015
Study Record Updates
Last Update Posted (Actual)
May 18, 2020
Last Update Submitted That Met QC Criteria
May 14, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A125548
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Testing and Monitoring of Blood Glucose Levels
-
Joslin Diabetes CenterRoche DiagnosticsCompletedGestational Diabetes MellitusUnited States
-
Institut für Diabetes-Technologie Forschungs- und...Ascensia Diabetes CareCompleted
-
Institut für Diabetes-Technologie Forschungs- und...Roche DiagnosticsCompleted
-
Institut für Diabetes-Technologie Forschungs- und...Completed
-
University Hospital, CaenCompletedOther Functional Disturbances Following Cardiac SurgeryFrance
-
Hospital Pablo Tobón UribeInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)CompletedHyperglycemia | Critical Illness | Insulin ResistanceColombia
-
Institut für Diabetes-Technologie Forschungs- und...LifeScanCompletedClinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS)Diabetes MellitusGermany
-
Institut für Diabetes-Technologie Forschungs- und...BayerCompleted
-
Radboud University Medical CenterEuropean Foundation for the Study of Diabetes; Dutch Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Hypoglycemia UnawarenessNetherlands
-
Sutter HealthGE Healthcare; University of California, Davis; LifeScanCompletedDiabetes Mellitus, Type 2United States